604 Page 1 of 5 Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder To Company Name/Scheme CLINUVEL PHARMACEUTICALS LTD ACN/ARSN/ABN 88 089 644 119 1. Details of substantial holder (1) Name JPMorgan Chase & Co. and its affiliates ACN/ARSN (if applicable)...
Change in substantial holding - Updated
Filed with ASX · · 32 pages · English
Release
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- Change in substantial holding
- Results of Meeting
- Chair address - amendment
- Managing Director Address
- Chair address
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals